Senior Consultant Kim White discussed cost implications and future considerations in Diabetes drug spending on the rise, as seen in Managed Healthcare Executive.

“It will take patients, providers and payers working together to ensure that the patient gets the right intervention at the right time to minimize the long-term cost impact of the disease,” she says.

Click here to read Tracey Walker’s full article.